Citing interim data from a study, the company said a smaller dose of its vaccine is safe and effective in kids ages 6-11, promoting a ‘robust’ immune response.
Moderna said Monday that its vaccine is safe for children ages 6-11 years old and promotes a "robust" immune response after two smaller doses, according to interim data from a study that comes just ahead of an FDA meeting to consider the shots for children.
2022-03-26
2022-03-26
2022-03-26
2022-03-26
Copyright 2022 AFCM